Related Experiment Videos
A purified ferredoxin from Giardia duodenalis
S M Townson1, G R Hanson, J A Upcroft
1Queensland Institute of Medical Research, Bancroft Center, Brisbane, Australia.
European Journal of Biochemistry
|March 1, 1994
Summary
Researchers purified a novel ferredoxin from Giardia duodenalis, identifying its role in electron transport and potential metronidazole activation. This discovery offers insights into parasite metabolism.
Area of Science:
- Biochemistry
- Parasitology
- Molecular Biology
Background:
- Giardia duodenalis is a protozoan parasite lacking characterized electron transport proteins.
- Ferredoxins are crucial low-molecular-weight electron carriers in various organisms.
Purpose of the Study:
- To purify and characterize the first ferredoxin from Giardia duodenalis.
- To investigate its biochemical properties and potential role in parasite metabolism and drug activation.
Main Methods:
- Protein purification to homogeneity.
- Spectroscopic analysis (UV-Vis absorption).
- Mass spectrometry and amino acid analysis.
- N-terminal sequencing.
- Electron paramagnetic resonance (EPR) spectroscopy.
- Biochemical assays for enzyme activity.
Main Results:
- A homogeneous ferredoxin was isolated, exhibiting characteristic absorption peaks at 296 and 406 nm.
- Molecular mass was determined to be approximately 5730 Da (apoprotein) with 4 cysteine residues.
- Amino acid sequence showed similarity to Desulfovibrio gigas ferredoxin II, suggesting iron-sulfur cluster coordination.
- Quantification revealed 3.21 mol sulfide and 2.65 mol iron per mole of protein.
- EPR studies confirmed the presence of an iron-sulfur center.
- The ferredoxin acts as an electron acceptor from giardial pyruvate dehydrogenase, with metronidazole as a terminal acceptor.
Conclusions:
- The characterized ferredoxin is the first electron transport protein identified in Giardia duodenalis.
- Its properties are consistent with known ferredoxins, coordinating an iron-sulfur cluster.
- The ferredoxin-mediated electron transfer pathway involving metronidazole suggests a mechanism for reductive drug activation in the parasite.
- Further research is needed to fully characterize a second identified ferredoxin and explore other low-molecular-mass electron transport proteins.